Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
Biotech
JPM: Novo CSO craves 'different flavors' of pipeline innovation
Novo is seeking to strengthen its obesity offerings while pursuing other indications that intersect with metabolism.
Darren Incorvaia
Jan 13, 2026 7:45am
2 biotechs scrounge for funds in year-end dealmaking spree
Dec 23, 2025 1:45pm
Edwards nets FDA approval for Sapien M3 mitral valve replacement
Dec 23, 2025 11:00am
Abbott's Volt pulsed field ablation system scores FDA approval
Dec 22, 2025 11:48am
Medtronic rolls out new peripheral thrombectomy system
Dec 17, 2025 9:50am
Philips claims AI cardiac imaging developer SpectraWAVE
Dec 15, 2025 10:35am
